Salmonella Genomic Characterization from Food and Patients in Ruian, China, 2020-2021
by Na Li·Updated 1mo ago
121.0 KB1files
Available on 1 platform
Sign in to view source links and access this dataset
Description
173 Salmonella isolates collected in Ruian City, China during 2020–2021, comprising 101 from diarrheal patients and 72 from food samples. The dataset includes serotyping, antimicrobial resistance phenotypes, and whole-genome sequencing results for virulence genes, resistance genes, and genetic relatedness. Author Na Li published the data under a CC-BY-4.0 license.
Use Cases
Compare serotype distribution between clinical and food isolates based on the 28 identified serovars.
Analyze antimicrobial resistance patterns based on phenotypes for amoxicillin, piperacillin, minocycline, and trimethoprim-sulfamethoxazole.
Study genetic relatedness and potential cross-transmission based on cgSNP phylogenomic analysis.
Investigate discrepancies between antimicrobial resistance genes and phenotypes based on the 91 detected ARGs.
Assess virulence potential based on virulence gene content patterns described for specific serovars like S. Rissen.
Strengths
Includes 173 isolates with clear source breakdown: 101 clinical and 72 food samples.
Provides phenotypic and genomic data for 28 distinct serovars and 31 sequence types.
Contains detailed resistance rates for specific antibiotics and multidrug-resistant rates for both sources.
Limitations
Column-level documentation is absent; field semantics must be inferred after download.
Row count is unknown, which may limit suitability assessment.
Data is limited to a specific city (Ruian) and time period (2020-2021), which may affect generalizability.
Provenance
Source
figshare
Collection Method
Whole-genome sequencing of archived isolates, serotyping, and antimicrobial resistance testing.
Time Range
2020–2021
Freshness
Last updated 2026-04-29 05:41:41; freshness should be verified.
Geography
Ruian City, China
File is in XLSX format; requires spreadsheet software or library for access.